GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 426 - 450 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgM Patient 1 10 moderate
G36191CD
35
IgM Patient 1 10 moderate
G69912LP
35
IgM Patient 1 10 moderate
G82096UQ
35
IgM Patient 1 10 moderate
G82204SH
35
IgG Patient 1 6 moderate
G81315DD
35
IgG Patient 1 6 moderate
G99603GB
35
IgM Patient 1 6 moderate
G00048MO
35
IgM Patient 1 6 moderate
G11460AB
35
IgM Patient 1 6 moderate
G36191CD
35
IgM Patient 1 6 moderate
G62826CL
35
IgG Patient 2 15 mild
G00054MO
35
IgG Patient 2 15 mild
G90562PB
35
IgG Patient 2 15 mild
G96865DJ
35
IgG Patient 2 24 mild
G02670IJ
35
IgG Patient 2 24 mild
G67045LB
35
IgG Patient 2 24 mild
G90562PB
35
IgM Patient 2 15 mild
G24432YB
35
IgG Patient 2 3 mild
G07483YN
35
IgM Patient 2 3 mild
G00054MO
35
IgG Patient 3 -180 mild
G19868AX
35
IgG Patient 3 -180 mild
G63074CQ
35
IgG Patient 3 -180 mild
G72739GY
35
IgG Patient 3 11 mild
G08520NM
35
IgG Patient 1 22 moderate
G03499BP
36
IgG Patient 1 22 moderate
G21675ZL
36

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024